Ultimaster™ DES Family
Our Brand Story: Ultimaster™
MASTER DAPT
Optimal DAPT duration
interview with clinical expert.
interview with clinical expert.
Deliver optimal results to every patient in your practice – no matter how complex the procedure.
With a global clinical program with over 50,000 patients, covering the most complex sub-groups, Ultimaster™ represents proven efficacy and safety you can rely on. In addition, our bio-inspired design and advanced polymer technology reduces the risk of complications and improves outcomes.
A routine procedure could turn into a complex case at any point, so it’s essential to have a tool you can trust. Ultimaster™ assures that you will be prepared for what’s coming next.
ULTIMASTER™ DES FAMILY. READY. SET. ACTION.
Bifurcation/LMT
INNOVATIVE TECHNOLOGY
New 10-crown design in the large vessel to ensure better apposition even in large bifurcations, including left main trunk1,2,3
EDUCATION
Learning from bench testing : Stent performance after overexpansion using
Lecture of Euro Bifurcation Club 16th consensus document
Long/Diffuse Lesion
INNOVATIVE TECHNOLOGY
New 44 & 50m lengths, for optimal sizing in long lesions1,2
High Bleeding Risk (HBR)
INNOVATIVE TECHNOLOGY
Abluminal gradient bioresorbable coating
EDUCATION
MASTER DAPT results can only be attributed to the UltimasterTM stent.
ITS RESULTS
MATER DAPT study result applies to the UltimasterTM DES Family.
UltimasterTM is the only stent with evidence showing that 1-month DAPT is safe and actually safer than a more prolonged regimen in high breeding risk patients.
Prof.Marco VALGIMIGLI